Vera Therapeutics, Inc. Class A (VERA)
NASDAQ · Manufacturing · Pharmaceutical preparations
VERA price, last 12 months
Key stats
- Previous close
- $25.58
- Open
- $25.60
- Day range
- $25.08 – $27.00
- 52-week range
- $25.08 – $56.05
- Volume
- 1.1M
- Avg volume (20 days)
- 1.4M
- Market cap
- $2.0B
Performance
Technicals and fundamentals
About Vera Therapeutics, Inc. Class A
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.0B